Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lammert

Showing results (1031-1040 of 1,090) with videos related to

Pageof 109
Sort By:
Hepatology Communications|January 29, 2024
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitisMaryam Yazdanfar, Joseph Zepeda, Richard Dean, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Hepatology Communications|February 15, 2024
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitisRebekka J S Salzmann, Christina Krötz, Tudor Mocan, et al.
Journal of Hepatology|August 8, 2021
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)Cornelius Engelmann, Adam Herber, Annegret Franke, et al.
Nature Genetics|July 17, 2007
A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone diseaseStephan Buch, Clemens Schafmayer, Henry Völzke, et al.
The American Journal of Gastroenterology|June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related CirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeM Moehler, A Maderer, C Schimanski, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Frontiers in Medicine|July 12, 2021
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLDVanda Marques, Marta B Afonso, Nina Bierig, et al.
Nature Communications|November 25, 2020
Common diseases alter the physiological age-related blood microRNA profileTobias Fehlmann, Benoit Lehallier, Nicholas Schaum, et al.
Pageof 109

Showing results (1031-1040 of 1,090) with videos related to

Sort By:
Pageof 109
Hepatology Communications|January 29, 2024
African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitisMaryam Yazdanfar, Joseph Zepeda, Richard Dean, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Hepatology Communications|February 15, 2024
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitisRebekka J S Salzmann, Christina Krötz, Tudor Mocan, et al.
Journal of Hepatology|August 8, 2021
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)Cornelius Engelmann, Adam Herber, Annegret Franke, et al.
Nature Genetics|July 17, 2007
A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone diseaseStephan Buch, Clemens Schafmayer, Henry Völzke, et al.
The American Journal of Gastroenterology|June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related CirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programmeM Moehler, A Maderer, C Schimanski, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Frontiers in Medicine|July 12, 2021
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLDVanda Marques, Marta B Afonso, Nina Bierig, et al.
Nature Communications|November 25, 2020
Common diseases alter the physiological age-related blood microRNA profileTobias Fehlmann, Benoit Lehallier, Nicholas Schaum, et al.
Pageof 109